HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Brian I Carr Selected Research

Yttrium

8/2012Some new approaches to the management of hepatocellular carcinoma.
3/2012Peripheral blood lymphocyte depletion after hepatic arterial 90Yttrium microsphere therapy for hepatocellular carcinoma.
3/2010Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study.
1/2009Hepatobiliary effects of 90yttrium microsphere therapy for unresectable hepatocellular carcinoma.
1/2008Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis.
2/2005Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis.
2/2005Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Brian I Carr Research Topics

Disease

53Hepatocellular Carcinoma (Hepatoma)
11/2015 - 01/2002
52Neoplasms (Cancer)
12/2015 - 01/2002
14Thrombosis (Thrombus)
10/2014 - 01/2007
8Fibrosis (Cirrhosis)
01/2014 - 11/2004
5Hepatitis
08/2012 - 02/2005
4Liver Neoplasms (Liver Cancer)
11/2014 - 09/2002
3Thrombocytopenia (Thrombopenia)
06/2014 - 01/2012
3Carcinoma (Carcinomatosis)
03/2012 - 05/2010
3Neoplasm Metastasis (Metastasis)
09/2010 - 06/2005
3Ascites
01/2010 - 01/2007
2Adenocarcinoma
03/2012 - 07/2010
2Pancreatic Neoplasms (Pancreatic Cancer)
07/2010 - 04/2010
1Alcoholism (Alcohol Abuse)
04/2015
1End Stage Liver Disease
11/2014
1Thrombocytosis (Thrombocythemia)
06/2013
1Circulating Neoplastic Cells
08/2012
1Liver Diseases (Liver Disease)
08/2012
1Hepatitis B
08/2012
1Obesity
08/2012
1Pain (Aches)
05/2010
1Fatigue
05/2010
1Ataxia Telangiectasia (Louis Bar Syndrome)
10/2009
1Cholangiocarcinoma
01/2008
1Portal Hypertension
01/2007
1Leukemia
07/2006
1Prostatic Neoplasms (Prostate Cancer)
07/2006
1Hepatic Insufficiency
01/2006
1Breast Neoplasms (Breast Cancer)
04/2005
1Lung Neoplasms (Lung Cancer)
05/2004
1Acute Cholecystitis
02/2004

Drug/Important Bio-Agent (IBA)

25alpha-Fetoproteins (AFP)IBA
11/2015 - 11/2004
18BilirubinIBA
10/2014 - 02/2005
142- (2- hydroxyethylsulfanyl)- 3- methyl- 1,4- naphthoquinoneIBA
12/2007 - 01/2002
12gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
10/2014 - 01/2007
9sorafenib (BAY 43-9006)FDA Link
07/2015 - 07/2010
9Phosphotransferases (Kinase)IBA
02/2013 - 12/2002
9VitaminsIBA
09/2011 - 02/2003
8Vitamin KFDA Link
01/2013 - 01/2002
7YttriumIBA
08/2012 - 02/2005
6DNA (Deoxyribonucleic Acid)IBA
10/2007 - 01/2002
5cdc25 PhosphatasesIBA
10/2008 - 05/2003
4Alkaline PhosphataseIBA
01/2014 - 01/2010
3acarboxyprothrombin (PIVKA)IBA
01/2013 - 03/2007
3Epidermal Growth Factor Receptor (EGF Receptor)IBA
03/2012 - 05/2002
3Vitamin K 3 (Menadione)FDA Link
10/2006 - 05/2003
3Protein Tyrosine PhosphatasesIBA
09/2003 - 08/2002
2Growth InhibitorsIBA
12/2015 - 11/2006
2Biological Markers (Surrogate Marker)IBA
01/2013 - 05/2010
2gemcitabineFDA Link
09/2010 - 01/2008
2Cisplatin (Platino)FDA LinkGeneric
09/2010 - 01/2008
2RTA 502IBA
10/2009 - 04/2009
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
08/2008 - 11/2006
2Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
12/2007 - 06/2005
2Fibronectins (Fibronectin)IBA
10/2007 - 09/2007
2Proteins (Proteins, Gene)IBA
09/2007 - 05/2003
2Tyrosine (L-Tyrosine)FDA Link
02/2003 - 08/2002
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2015
1Angiotensin Receptors (Angiotensin II Receptor)IBA
11/2015
1Angiotensin IIIBA
11/2015
1Angiotensin II Type 1 Receptor BlockersIBA
11/2015
1Aflatoxin B1 (Aflatoxin B)IBA
04/2015
1Ferritins (Ferritin)IBA
11/2014
1Aspartic Acid (Aspartate)FDA Link
06/2014
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
06/2014
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2014
1Keratins (Keratin)IBA
01/2013
1antigen CYFRA21.1IBA
01/2013
1CA-125 Antigen (CA 125 Antigen)IBA
01/2013
1tyrosine receptor (receptor, tyrosine)IBA
08/2010
1Carbon MonoxideIBA
04/2010
1ThrombomodulinIBA
01/2009
1Mercaptoethanol (2 Mercaptoethanol)IBA
10/2008
1Estrogens (Estrogen)FDA Link
10/2008
12-methoxyestradiolIBA
10/2008
1oxaliplatin (Eloxatin)FDA LinkGeneric
01/2008
1ThrombinFDA Link
10/2007
1CollagenIBA
09/2007
1Prothrombin (Factor II)IBA
09/2007
1lentil lectinIBA
03/2007
1benzoquinone (quinone)IBA
10/2006
1Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2006
1Mitogen-Activated Protein Kinase 3IBA
06/2006
1maleimideIBA
06/2006
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
07/2005
12,3- bis(2- hydroxyethylsulfanyl)- (1,4)naphthoquinoneIBA
04/2005
12- (2- mercaptoethanol)- 3- methyl- 1,4- naphthoquinoneIBA
12/2004
1ArsenicIBA
05/2004
1OxidoreductasesIBA
04/2004
1NADPH-Ferrihemoprotein Reductase (Cytochrome P450 Reductase)IBA
04/2004
1Cytochromes b5 (Cytochrome b5)IBA
04/2004

Therapy/Procedure

12Microspheres (Microsphere)
03/2012 - 09/2002
7Drug Therapy (Chemotherapy)
12/2015 - 01/2002
5Liver Transplantation
09/2012 - 11/2004
3Palliative Care (Palliative Medicine)
03/2013 - 07/2005
3Transplants (Transplant)
09/2012 - 01/2006
3Radiotherapy
08/2012 - 01/2008
2Aftercare (After-Treatment)
05/2008 - 07/2005
1Heterologous Transplantation (Xenotransplantation)
07/2006
1Intra-Arterial Injections
02/2005
1Cholecystectomy
02/2004